VSC Ventures — 2022 Investments
2 investments dated 2022 · listed companies and verified rows first · show all
NeuraLight develops AI-powered digital biomarkers for neurological diseases including Alzheimer's, Parkinson's, and multiple sclerosis.
AI & Machine LearningBiotechHealthtechMedical DevicesTel Aviv, IL
Edmund Ben-Ami(Founder)inEdmund Benami(Founder)Gil Shklarski(Founder)in
BoardProf. Thomas SüdhofProf. Olivier Rascol
Co-investorsMS&AD VenturesBreyer CapitalKoch Disruptive TechnologiesSamsung NextKli CapitalOperator Partners+2 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Empower3d
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.